Skip to main content
HR 437 115th Congress House Emergency Management Drug therapy Emergency medical services and trauma care Emergency planning and evacuation First responders and emergency personnel Hazardous wastes and toxic substances Health programs administration and funding Health technology, devices, supplies Infectious and parasitic diseases Terrorism

Medical Preparedness Allowable Use Act

Introduced: January 11, 2017 Introduced by: Bilirakis, Gus M. Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 1, 2017
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Jan 31, 2017
Motion to reconsider laid on the table Agreed to without objection.
Jan 31, 2017
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H797)
Jan 31, 2017
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H797)
Jan 31, 2017
DEBATE - The House proceeded with forty minutes of debate on H.R. 437.
Jan 31, 2017
Considered under suspension of the rules. (consideration: CR H797-798)
Jan 31, 2017
Mr. Donovan moved to suspend the rules and pass the bill.
Jan 12, 2017
Sponsor introductory remarks on measure. (CR H403)
Jan 11, 2017
Referred to the House Committee on Homeland Security.
Jan 11, 2017
Introduced in House
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Medical Preparedness Allowable Use Act

(Sec. 2) This bill amends the Homeland Security Act of 2002 to authorize the use of Urban Area Security Initiative and State Homeland Security Grant Program funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities, including the development and maintenance of an initial pharmaceutical stockpile, including medical kits, and diagnostics sufficient to protect first responders, their families, immediate victims, and vulnerable populations from a chemical or biological event.

What's happening now February 1, 2017

Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

 Committees of jurisdiction 2